Journal of the Chinese Medical Association
Volume 70, Issue 4 , Pages 141-145 , April 2007

Hepatitis B Virus-related Hepatocellular Carcinoma: Epidemiology and Pathogenic Role of Viral Factors

  • Chun-Jen Liu

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Jia-Horng Kao

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Taipei, Taiwan, R.O.C.
    • Graduate Institute of Clinical Medicine, Taipei, Taiwan, R.O.C.
    • Hepatitis Research Center, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Professor Jia-Horng Kao, Hepatitis Research Center, National Taiwan University Hospital, 1, Chang-Te Street, Taipei 100, Taiwan, R.O.C.

Received 4 December 2006 ,Accepted 12 March 2007.

References 

  1. Parkin DM , Stjernsward T , Muir CS . Estimates of the worldwide frequency of twelve major cancers . Bull World Health Organ . 1984;62:163–182
  2. El-Serag HB . Epidemiology of hepatocellular carcinoma . Clin Liver Dis . 2001;5:87–107
  3. Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, et al  Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan . Int J Cancer . 2006;119:1946–1952
  4. Huang YH, Wu JC, Chau GY, Tsay SH, King KL, Sheng WY, et al  Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients . J Gastroenterol . 1998;33:512–516
  5. Lu SN, Chue PY, Chen HC, Wu MH, Chen IL, Huang JF, et al  Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan . J Gastroenterol Hepatol . 1997;12:547–550
  6. Lee SD , Lee FY , Wu JC , Hwang SJ , Wang SS , Lo KJ . The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma . Cancer . 1992;69:342–345
  7. Bosch FX , Ribes J , Diaz M , Cleries R . Primary liver cancer: worldwide incidence and trends . Gastroenterology . 2004;127:5–16
  8. Chen DS . From hepatitis to hepatoma: lessons from type B viral hepatitis . Science . 1993;262:369–370
  9. Kao JH , Chen DS . Overview of hepatitis B and C viruses . In:  Goedert JJ editors. Infectious Causes of Cancer: Targets for Intervention . Tottowa: Humana Press Inc.; 2000;p. 313–330
  10. De Vos Irvine H , Goldberg D , Hole DJ , McMenamin J . Trends in primary liver cancer . Lancet . 1998;351:215–216
  11. Trevisani F, D'Intimo PE, Caraceni P, Pizzo M, Stefanini GF, Mazziotti A, et al  Etiologic factors and clinical presentation of hepatocellular carcinoma: differences between cirrhotic and noncirrhotic Italian patients . Cancer . 1995;75:2220–2232
  12. Margolis HS . Hepatitis B virus infection . Bull World Health Organ . 1998;76:152–153
  13. Kane M . Global programme for control of hepatitis B infection . Vaccine . 1995;13(Suppl):47–49
  14. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al  Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination . Ann Intern Med . 2001;135:796–800
  15. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group . N Engl J Med . 1997;336:1855–1859
  16. Kao JH , Chen DS . Global control of hepatitis B virus . Lancet Infect Dis . 2002;2:395–403
  17. Kao JH , Chen DS . Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia . Liver Int . 2005;25:696–703
  18. Department of Health, Executive Yuan, R.O.C. Republic of China Health and Vital Statistics, 1981-97.
  19. Okuda K , Fujimoto I , Hanai A , Urano Y . Changing incidence of hepatocellular carcinoma in Japan . Cancer Res . 1987;47:4967–4972
  20. Taylor-Robinson SD , Foster GR , Arora S , Hargreaves S , Thomas HC . Increase in primary liver cancer in the UK, 1979-94 . Lancet . 1997;350:1142–1143
  21. Deuffic S , Poynard T , Buffat L , Valleron AJ . Trends in primary liver cancer . Lancet . 1998;351:214–215
  22. El-Serag HB , Mason AC . Rising incidence of hepatocellular carcinoma in the United States . N Engl J Med . 1999;340:745–750
  23. El-Serag HB . Hepatocellular carcinoma: recent trends in the United States . Gastroenterology . 2004;127(Suppl):27–34
  24. Okuda K . Liver cancer . In:  Zuckerman AJ ,  Thomas HC editor. Viral Hepatitis: Scientific Basis and Clinical Management . London: Churchill Livingstone; 1993;p. 269–280
  25. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, et al. Hepatocellular carcinoma: recent trends in Japan . Gastroenterology . 2004;127:17–26
  26. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, et al. Inaugural article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades . Proc Natl Acad Sci USA . 2002;99:15584–15589
  27. Murakami S . Hepatitis B virus X protein: a multifunctional viral regulator . J Gastroenterol . 2001;36:651–660
  28. Arbuthnot P , Capovilla A , Kew M . Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways . J Gastroenterol Hepatol . 2000;15:357–368
  29. Oda T , Tsuda H , Scarpa A , Sakamoto M , Hirohashi S . p53 gene mutation spectrum in hepatocellular carcinoma . Cancer Res . 1992;52:6358–6364
  30. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocel-lular carcinomas . Proc Natl Acad Sci USA . 1998;95:8847–8851
  31. Wu BK, Li CC, Chen HJ, Chang JL, Jeng KS, Chou CK, et al  Blocking of G1/S transition and cell death in the regenerating liver of hepatitis B virus X protein transgenic mice . Biochem Biophys Res Commun . 2006;340:916–928
  32. Chen BF , Liu CJ , Jow GM , Chen PJ , Kao JH , Chen DS . Higher prevalence and mapping of pre-S deletion in chronic hepatitis B with cirrhosis and hepatocellular carcinoma . Gastroenterology . 2006;130:1153–1168
  33. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, et al  Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage . Carcinogenesis . 2004;25:2023–2032
  34. Norder H , Courouce AM , Magnius LO . Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes . Virology . 1994;198:489–503
  35. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, et al  Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes . Virology . 1992;188:331–341
  36. Liu CJ , Kao JH , Chen DS . Therapeutic implications of hepatitis B virus genotypes . Liver Int . 2005;25:1097–1107
  37. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al  Hepatitis B virus genotype and DNA level and hepatocel-lular carcinoma: a prospective study in men . J Natl Cancer Inst . 2005;97:265–272
  38. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, et al  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice . Nat Med . 1998;4:1065–1067
  39. Kao JH , Chen PJ , Lai MY , Chen DS . Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers . Gastroenterology . 2003;124:327–334
  40. Minami M , Poussin K , Kew M , Okanoue T , Brechot C , Paterlini P . Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed on noncirrhotic livers . Gastroenterology . 1996;111:691–700
  41. Kao JH , Chen PJ , Lai MY , Chen DS . Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B . Gastroenterology . 2000;118:554–559
  42. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level . JAMA . 2006;295:65–73
  43. Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, et al. Role of hepatitis B viral load and core promoter mutation on hepatocellular carcinoma in hepatitis B carriers . J Infect Dis . 2006;193:1258–1265
  44. Ou LH, Chau GY, Tsay SH, Chiu JH, Wu JC, King KL, et al  Clinicopathological comparison of respectable hepatocellular carcinoma between the young and the elderly patients . Chin Med J . 1997;60:40–47
  45. Tsai FC, Liu CJ, Chen CL, Chen PJ, Lai MY, Kao JH, et al. Lower serum viral loads in young patients with hepatitis B virus-related hepatocellular carcinoma . J Viral Hepat . 2007;14:153–160
  46. Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, et al  Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma . Gastroenterology . 2004;127:1733–1738
  47. Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on non-cirrhotic hepatocellular carcinoma: a case control study . J Infect Dis . 2006;194:594–599
  48. Kao JH , Chen DS . HBV genotypes: epidemiology and implications regarding natural history . Curr Hepatitis Rep . 2006;5:5–13
  49. Brechot C . Pathogenesis of hepatitis B virus-related hepatocel-lular carcinoma: old and new paradigms . Gastroenterology . 2004;127(Suppl):56–61

PII: S1726-4901(09)70346-6

doi: 10.1016/S1726-4901(09)70346-6

Journal of the Chinese Medical Association
Volume 70, Issue 4 , Pages 141-145 , April 2007

Article Tools